![Kevan Shokat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevan Shokat
No open positions remaining
Profile
Kevan Shokat is the founder of Intellikine LLC, founded in 2007.
Dr. Shokat is the founder of eFFECTOR Therapeutics Operations, Inc., founded in 2012.
Dr. Shokat is the founder of eFFECTOR Therapeutics, Inc., founded in 2012.
Dr. Shokat is the founder of Revolution Medicines, Inc., founded in 2014.
Dr. Shokat is the founder of Erasca, Inc., founded in 2018.
Dr. Shokat is the founder of Nested Therapeutics, Inc., founded in 2021.
Dr. Shokat is also the founder of Rezo Therapeutics, Inc.,Mitokinin, Inc. Dr. Shokat served as a Scientific Advisor at 5AM Venture Management LLC.
Dr. Shokat earned a doctorate from the University of California, Berkeley.
Former positions of Kevan Shokat
| Companies | Position | End |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Founder | 2016-12-17 |
| ERASCA, INC. | Founder | - |
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Founder | - |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Founder | - |
| EFFECTOR THERAPEUTICS, INC. | Founder | - |
Training of Kevan Shokat
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Mitokinin, Inc.
 Mitokinin, Inc. BiotechnologyHealth Technology Develops kinase neo-substrates for the treatment of neurodegenerative and mitochondrial diseases | Health Technology |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Commercial Services |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
- Stock Market
- Insiders
- Kevan Shokat
